
Steven J Chmura MD PhD. Professor and Chair of Breast Radiation ☢️ Oncology studying #oligometastases #EndCancer
Joined January 2009
- Tweets2.1K
- Following156
- Followers582
- Likes1.8K
Steven Chmura MD, PhD retweeted
Replying to @rweichselbaum @TonyFelefly @pipcosper @CJTsaiMDPhD @subatomicdoc @Docace911 @NRGonc @SeanPitroda @JCO_ASCO @DavidKrugMD @CASRA_SABR @safaviaa @IBCradiation
It’s worth noting there is actually another completed trial that is the largest of the bunch from Egypt. They were all newly diagnosed and the results were firmly negative.
am25.astro.org/sessions/ss-2…
Steven Chmura MD, PhD retweeted
Good to see this finally in print @Docace911!
Now out in #JCO!
NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer. Co-authored by @Docace911
Read the article. bit.ly/3VGspka
#BreastCancer #bcsm
Steven Chmura MD, PhD retweeted
CTCs interact with the arms - prompts the hypothesis that ablation is beneficial if micrometatstatic systemic disease is controlled. New concept being evaluated at NCI next month. 🤞🏻🤞🏻
Steven Chmura MD, PhD retweeted
Such a Bright future. So many rockstars.
This quoted post is unavailable.
Steven Chmura MD, PhD retweeted
Happy to present our work led by excellent PGY4 @ConnorLynchMD on a pooled analysis of liver SBRT and immunotherapy in patients with polymetastatic disease treated on three phase 1 trials @UCCancerCenter. redjournal.org/article/S0360… We show that:
Steven Chmura MD, PhD retweeted
In our #AskAScientist series on promising areas of cancer research for those starting their scientific careers, Ludwig @UChicagoMed’s Ralph Weichselbaum highlights bioinformatic analysis as a key skill for future researchers.
Steven Chmura MD, PhD retweeted
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy - ScienceDirect Congrats @rweichselbaum @Docace911 and team!! #radonc sciencedirect.com/science/ar…
Steven Chmura MD, PhD retweeted
Wonderful night celebrating our talented residents at our end of year graduation dinner. Looking forward to following the careers of a truly amazing class @jarah_md @RohanKatipally @grozomah
@UChicagoRadonc
Steven Chmura MD, PhD retweeted
Celebrating our wonderful clinical trial staff who make cutting edge research possible and accessible to our patients !! @UChicagoRadonc
@UCCancerCenter @Docace911 @jarah_md @RohanKatipally
Steven Chmura MD, PhD retweeted
Replying to @jasonlukemd @Docace911 @UPMCHillmanCC @PittDeptofMed @UCCancerCenter @Ludwig_Cancer @radoncadonk1 @RadiumSociety @ASTRO_org @jclinicalinvest @mkorps42
There definitely is a bad scopal in some cases! Coming soon, May 25! This is great work however, when did parameters to see who will get immune stimulation or inhibitors
Steven Chmura MD, PhD retweeted
With @Docace911 we present our dogma challenging #RadOnc & #immunotherapy manuscript showing safety & prelim efficacy of partial tumor irradiation with anti-PD1. In contrast w aBscopal, we suggest an aDscopal effect where IO enhances local #radiation.
jci.org/articles/view/162260
Steven Chmura MD, PhD retweeted
One day we will learn that overworking people is not beneficial. We will fix being short-staffed before it becomes an unsustainable problem. Until then, my vacation is worth gold.
Steven Chmura MD, PhD retweeted
Dr. Julia White will discuss the NRG-BR007 DEBRA Trial today during a poster presentation at #SABCS22. This #clinicaltrial is looking at reducing the use of breast radiation after lumpectomy for people with low-risk, early-stage #breastcancer. Learn more: nrgoncology.org/DEBRA-Trial
Steven Chmura MD, PhD retweeted
📢Excited that our new IIT evaluating ctDNA response-adaptive IO-based therapy in #headandneckcancer now open to accrual @UCCancerCenter! Thank you to @CancerRF for the support! 🧑🔬🔬clinicaltrials.gov/ct2/show/…
Steven Chmura MD, PhD retweeted
Two fantastic papers published this week in @NatureCancer & @NatureGenet by @SeanPitroda and his team. This work demonstrates the need for concurrent radiation and immunotherapy for certain mNSCLC patients. @UChicagoMed @UCCancerCenter
@lfspurr
ow.ly/qQTf50LRwKU
Remember the NULL: fun to respond to this commentary with my good colleague @Dr_Julia_White and in my role as Hand to the King @IBCradiation @NRGonc @UChicagoBreast
Reply to J. Widder ascopubs.org/doi/full/10.120…
Steven Chmura MD, PhD retweeted
📣 OUT NOW @NatureGenet
📰 Tumor aneuploidy predicts survival following immunotherapy across multiple cancers
🧑🏿🤝🧑🏽 @SeanPitroda and team
👇🏽
go.nature.com/3gLfoSk































